Gonadal Function in Children With Nephrosis Treated With Cyclophosphamide
- 1 March 1975
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 129 (3) , 315-318
- https://doi.org/10.1001/archpedi.1975.02120400027006
Abstract
Gonadal function was evaluated in 23 boys and 11 girls treated with cyclophosphamide, 2 to 5 mg/kg/day for periods of 1.5 to 6 months. Serum follicle stimulating hormone (FSH), luteinizing hormone (LH), and testosterone levels were determined by radioimmunoassay. All 16 boys treated when prepubertal or during early puberty had normal FSH, LH, and testosterone levels. Testicular biopsy was performed in five of the 16, and was abnormal in four and normal in one. Sperm count was normal in two other patients. The remaining seven boys were treated when pubertal; all have decreased spermatogenesis, and five of them have increased FSH levels. The LH and testosterone levels were normal. No evidence of gonadal dysfunction was detected in any of the girls. Of four patients treated when postpubertal, three have become pregnant.Keywords
This publication has 5 references indexed in Scilit:
- Malignant mixed mullerian tumor of the cervix following cyclophosphamide therapy for nephrotic syndromeThe Journal of Pediatrics, 1973
- Serum Follicular-Stimulating Hormone and Luteinizing Hormone as Measured by Radioimmunoassay Correlated with Sexual Development in Hypopituitary SubjectsJournal of Clinical Investigation, 1972
- Multiple late complications of therapy with cyclophosphamide, including ovarian destructionThe American Journal of Medicine, 1971
- CONTROLLED TRIAL OF CYCLOPHOSPHAMIDE IN STEROID-SENSITIVE RELAPSING NEPHROTIC SYNDROME OF CHILDHOODThe Lancet, 1970
- Cyclophosphamide Therapy in the Nephrotic Syndrome in ChildhoodBMJ, 1969